Please use this identifier to cite or link to this item:
Title: Telogen effluvium.
Epworth Authors: Sinclair, Rodney
Other Authors: Liyanage, Deepa
Keywords: Diffuse Hair Loss
Telogen Effluvium
Hair Loss
Hair Shedding
Clinical Presentations
Acute TE
Acute Telogen Effluvium
Chronic TE
Chronic Telogen Effluvium
Department of Dermatology. Epworth HealthCare, Victoria, Australia
Issue Date: Mar-2016
Publisher: MDPI AG
Citation: Cosmetics 2016, 3(2), 13.
Abstract: Kligman first coined the term telogen effluvium (TE) in 1961 to describe the state of increased shedding of otherwise normal telogen hairs. TE may be primary or secondary to a wide variety of potential triggers including febrile illness, drugs, thyroid disorders, and child birth. The diagnosis of secondary TE can be made by identifying known triggers from the history in the 3–4 months preceding the onset of increased hair shedding and by investigating to exclude endocrine, nutritional, or auto immune aetiologies. Scalp biopsy to identify the earliest stages of androgenetic alopecia may be required in some cases. Primary TE may be acute or chronic. In acute TE, the shedding resolves within 3–6 months and the hair density recovers completely. In chronic TE, the shedding can continue with minor fluctuations in severity for decades. In this review, possible causative factors, pathogenesis, clinical presentations and treatment options are discussed.
DOI: 10.3390/cosmetics3020013
ISSN: 2079-9284
Journal Title: Cosmetics
Type: Journal Article
Type of Clinical Study or Trial: Review
Appears in Collections:Dermatology
Head & Neck

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.